Details for New Drug Application (NDA): 090279
✉ Email this page to a colleague
The generic ingredient in BUPRENORPHINE HYDROCHLORIDE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
Summary for 090279
Tradename: | BUPRENORPHINE HYDROCHLORIDE |
Applicant: | Rubicon |
Ingredient: | buprenorphine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 090279
Mechanism of Action | Partial Opioid Agonists |
Suppliers and Packaging for NDA: 090279
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPRENORPHINE HYDROCHLORIDE | buprenorphine hydrochloride | TABLET;SUBLINGUAL | 090279 | ANDA | Advagen Pharma Ltd | 72888-182 | 72888-182-30 | 30 TABLET in 1 BOTTLE (72888-182-30) |
BUPRENORPHINE HYDROCHLORIDE | buprenorphine hydrochloride | TABLET;SUBLINGUAL | 090279 | ANDA | Advagen Pharma Ltd | 72888-182 | 72888-182-90 | 90 TABLET in 1 BOTTLE (72888-182-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Jun 10, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 8MG BASE | ||||
Approval Date: | Jun 10, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription